Skip to main content

Table 5 Study measurements in the clinical groups excluding repeat samples

From: A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection

Clinical group

Controls

(n = 13)

Not Infected (n = 89)

Infected (n = 46)

  
    

Culture positive (n = 26)

Culture Negative (n = 20)

sICAM-1 (ng/ml),

155 (118,228)

164

(138,200)

300

(198,488)

P < 0.001

346

(215,568)

P < 0.001

268 (190,339)

P < 0.001

hsCRP(mg/l),

0.1 (0.1,0.25)

0.1

(0.1,1.0)

1.0

(0.4,15.8)

P < 0.001

1.6 (0.7,20.0)

P < 0.001

0.85 (0.1,6.0)

P = 0.017

SAA(mg/l)

0.9 (0.9,1.0)

1.0

(0.9,2.0)

2.0

(0.9,4.8)

P = 0.021

2.0

(0.9-5.8)

P = 0.007

1.0

(0.9,2.8)

P > 0.05

sE-selectin(ng/ml)

61

(52,101)

82

(58,120)

104

(84,176)

P < 0.001

150

(93,196)

P < 0.001

98

(63,150)

P > 0.05

  1. Results excluding repeat samples from individual infants. Only the first episode is included for each infant. Levels of test measurements in each clinical group and duration of antibiotic therapy is provided. All data quoted as (median, (1st, 3rd quartiles)). Statistical comparison between infected and not infected groups (Mann Whitney U test). Highly significant elevations (P < 0.001) highlighted in bold. Control samples not included in statistical analysis.